Vertex Pharmaceuticals lists 10 executives, led by Reshma Kewalramani FASN, M.D., CEO, President & Director (age 52). Charles F. Wagner Jr. is the company's Executive VP, COO & CFO (age 57).
In fiscal year 2025 the highest-paid executive was Reshma Kewalramani FASN, M.D., CEO, President & Director, with total pay of $6.14 million. The 5 executives with reported pay received $15.35 million in all.
The average age of the executives with a known age is 56; the youngest is 47 and the oldest 69.
Titles, ages and pay from company filings; pay for fiscal year 2025.

Executive Chairman
CEO, President & Director
Executive VP, COO & CFO
Executive VP & Chief Patient and External Affairs Officer
Executive VP & Chief Product Affairs Officer
Executive VP of Global Medicines Development & Medical Affairs and Chief Medical Officer
Senior VP & Chief Accounting Officer
Executive VP & Chief Scientific Officer
Senior Vice President of Investor Relations
EVP, Chief Legal Officer & Corporate Secretary
| Executive | Title | Age | Total pay |
|---|---|---|---|
| Reshma Kewalramani FASN, M.D. | CEO, President & Director | 52 | $6.14 million |
| Charles F. Wagner Jr. | Executive VP, COO & CFO | 57 | $2.99 million |
| Carmen Bozic M.D. | Executive VP of Global Medicines Development & Medical Affairs and Chief Medical Officer | 62 | $2.27 million |
| Ourania Tatsis Ph.D. | Executive VP & Chief Product Affairs Officer | 55 | $2.07 million |
| Amit K. Sachdev J.D. | Executive VP & Chief Patient and External Affairs Officer | 57 | $1.88 million |
Total pay as reported for the fiscal year; it can include salary, bonus and stock awards.
Reshma Kewalramani FASN, M.D. (CEO, President & Director), age 52; total pay in fiscal year 2025 was $6.14 million.
Charles F. Wagner Jr. (Executive VP, COO & CFO), age 57.
Reshma Kewalramani FASN, M.D., CEO, President & Director, with total pay of $6.14 million in fiscal year 2025.
Jeffrey Marc Leiden M.D., Ph.D. (Executive Chairman), Reshma Kewalramani FASN, M.D. (CEO, President & Director), Charles F. Wagner Jr. (Executive VP, COO & CFO), Amit K. Sachdev J.D. (Executive VP & Chief Patient and External Affairs Officer) and Ourania Tatsis Ph.D. (Executive VP & Chief Product Affairs Officer), and 5 more.